Medindia

X

IMPORTANT CORRECTION OF DRUG INFORMATION about EMBEDA(R) (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules for oral use C-II

Saturday, March 27, 2010 Drug News J E 4
Advertisement

Eric G. Carter, Ph.D., M.D.

Chief Science Officer

CONTACT:

Jack Howarth

Vice President

Investor Relations

+1-908-429-8350

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Service Corporation International Announces Succes...
S
Extensis Group and the Marquis Agency to Host Busi...